Sanjay N. Mandhane

Vadodara, GJ, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Recent Comparative Advances in the Mechanistic Actions and Translational Relevance of Syringic Acid and Vanillic Acid for Oxidative Stress-Associated Disorders.

Recent Comparative Advances in the Mechanistic Actions and Translational Relevance of Syringic Acid and Vanillic Acid for Oxidative Stress-Associated Disorders.

Journal: Recent advances in food, nutrition & agriculture

Published: February 06, 2026

Preclinical Evaluation of a Novel Once-a-Day Brimonidine Ophthalmic Nanosuspension.

Preclinical Evaluation of a Novel Once-a-Day Brimonidine Ophthalmic Nanosuspension.

Journal: Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics

Published: August 30, 2023

Syringic Acid Ameliorates Cardiac, Hepatic, Renal and Neuronal Damage Induced by Chronic Hyperglycaemia in Wistar Rats: A Behavioural, Biochemical and Histological Analysis.

Syringic Acid Ameliorates Cardiac, Hepatic, Renal and Neuronal Damage Induced by Chronic Hyperglycaemia in Wistar Rats: A Behavioural, Biochemical and Histological Analysis.

Journal: Molecules (Basel, Switzerland)

Published: August 22, 2022

Complete Tumor Regression by Liposomal Bortezomib in a Humanized Mouse Model of Multiple Myeloma.

Complete Tumor Regression by Liposomal Bortezomib in a Humanized Mouse Model of Multiple Myeloma.

Journal: HemaSphere

Published: March 27, 2020

Development and characterization of liposomal formulation of bortezomib.

Development and characterization of liposomal formulation of bortezomib.

Journal: International journal of pharmaceutics: X

Published: January 08, 2019

Liposomal dexamethasone inhibits tumor growth in an advanced human-mouse hybrid model of multiple myeloma.

Liposomal dexamethasone inhibits tumor growth in an advanced human-mouse hybrid model of multiple myeloma.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: September 28, 2018

Nanomedicines for the treatment of hematological malignancies.

Nanomedicines for the treatment of hematological malignancies.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: June 20, 2018

Induction of glucose intolerance by acute administration of rimonabant.

Induction of glucose intolerance by acute administration of rimonabant.

Journal: Pharmacology

Published: January 31, 2012

Allergic rhinitis: an update on disease, present treatments and future prospects.

Allergic rhinitis: an update on disease, present treatments and future prospects.

Journal: International immunopharmacology

Published: March 03, 2011

Characterization of anti-inflammatory properties and evidence for no sedation liability for the novel antihistamine SUN-1334H.

Characterization of anti-inflammatory properties and evidence for no sedation liability for the novel antihistamine SUN-1334H.

Journal: International archives of allergy and immunology

Published: October 23, 2008

Preclinical efficacy and safety pharmacology of SUN-1334H, a potent orally active antihistamine agent.

Preclinical efficacy and safety pharmacology of SUN-1334H, a potent orally active antihistamine agent.

Journal: Drugs in R&D

Published: February 27, 2008

Showing 1-11 of 11

Last Updated: 09/26/2026